Myocardial Infarction, Deep Venous Thrombosis and Pulmonary Embolism in COVID-19 Hospitalizations: Stats from the Nationwide Inpatient Sample 2020
Issue: 2023 - Volume 12 [Issue 4]
Evbayekha Endurance *
St Luke’s Hospital, Chesterfield, Missouri, USA.
Nuvance/Vassa Brother Medical Center, Poughkeepsie, New York, USA.
Delta State University, Abraka, Delta State, Nigeria.
Igbinedion University, Benin City, Nigeria.
Abiola Yetunde Oyesile
Dnipropetrovsk Medical Institute, Ukraine.
Richmond Gabriel University School of Medicine, the Grenadines.
Chinemerem Martlin Emeasoba
Imo State University, Owerri, Nigeria.
Bolanle Hawau Salaudeen
Lagos State University College of Medicine, Lagos, Nigeria.
Anita Ogochukwu Onyekwere
Richmond Gabriel University School of Medicine, the Grenadines.
Awanwosa Valentine Agho
University of Benin, Benin City, Nigeria.
Georgia Southern University, Statesboro, USA.
Adeniyi Kayode Busari
Emory University, Atlanta, Georgia, USA.
Agatha Olawunmi Akinsete
Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.
University of Lagos, Lagos, Nigeria.
Ibilola Akorede Sanusi
UT Health Houston, Houston, Texas, USA.
Western Illinois University, Macomb, Illinois, USA.
Victor Ameh Odoma
Indiana University, Bloomington, Indiana, USA.
Lovette Ugonma Oji
Abia State University, Aba, Nigeria.
Emeka Kenneth Okobi
Ahmadu Bello University Teaching Hospital, Zaria, Nigeria.
Ohikhuai Eseose Evidence
Jackson State University, Mississippi, USA.
Okelue Edwards Okobi
Palm Springs General Hospital, Hialeah, Florida, USA.
*Author to whom correspondence should be addressed.
Background: The outcomes of SARS-CoV-2 (COVID) hospitalizations and their association with myocardial injury and thrombosis were studied. We aimed to provide further insights into the impact of COVID-19 on modern-day healthcare.
Methods: Retrospective analysis of the National Inpatient Sample 2020 database. We used the International Classification of Disease Code, Tenth Edition (ICD-10) to identify all hospitalizations with COVID-19. We then conducted a subgroup analysis of the population of interest: Those who also developed myocardial infarction, pulmonary embolism, and deep venous thrombosis.
Results: 335,799 hospitalizations with COVID. Of these, 1.6% (5,355) were diagnosed with non-ST-segment myocardial infarction (COVNSTEMI) were identified. The mean age of COVID-19 hospitalizations was 71.7, with 60.50% males. The population prevalence included 53.10% Whites, 17.80% Blacks, 19.20% Hispanics, and 4.10% Asians. The average Length of stay (LOS) was 10 days, and 37.60% of patients died during hospitalization. The average cost of hospitalization (TOTCHG) was $156,633. The COVSTEMI group comprised 1,364 cases, with a mean age of 67.4, in-hospital mortality of 47.4%, and the mean TOTCHG was $177,600. The DVTCOV group comprised 2,869 cases, while the PECOV group had 4,828 cases. Male predominance was observed in both groups, with mean ages of 66 years in the DVTCOV group and 64 years in the PECOV group. The DVTCOV group had a LOS of 16 days, with 24.71% mortality, while the PECOV group had a LOS of 11 days, with 19.20% mortality. The average TOTCHG in the DVTCOV group was $248,900, whereas it was $145,378 in the PECOV group.
Conclusion: Our study revealed significant mortality rates across different groups, including 38% in COVNSTEMI, 47% in COVSTEMI, 25% in DVTCOV, and 19% in PECOV. These findings highlight the severity of COVID-related complications and the substantial financial burden of hospitalization.
Keywords: SARS-CoV-2, COVID-19, Pulmonary embolism, PE, deep venous thrombosis, DVT, hospitalization
How to Cite
Umakanthan S, Sahu P, Ranade A, et al.: Origin, transmission, diagnosis, and Management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96:753-758. DOI: 10.1136/postgradmedj-2020-138234
Weekly Review. https://covid.cdc.gov/covid-data-tracker. Assessed 2/14.2023
Available:https://covid19.who.int. accessed 2/14/2023
Miller IF, Becker AD, Grenfell BT, et al.: Disease and healthcare burden of COVID-19 in the United States. Nat Med. 2020;26:1212-1217. DOI:10.1038/s41591-020-0952-y
Potere N, Valeriani E, Candeloro M, et al. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis. Crit Care. 2020;24.
Driggin E, Madhavan M, Bikdeli B, et al.: Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020;75:2352-2371. DOI:10.1016/j.jacc.2020.03.031
Clerkin KJ, Fried JA, Raikhelkar J, et al.: COVID-19 and Cardiovascular Disease. Circulation. 2020;141:1648-1655.
Madjid M, Safavi-Naeini P, Solomon SD, et al.: Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020;5:831-840. DOI:10.1001/jamacardio.2020.1286
Klok FA, Kruip MJHA, van der Meer NJM, et al.: Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191: 145-147. DOI:10.1016/j.thromres.2020.04.013
Bikdeli B, Madhavan M: v. Jimenez D, et al., COVID-19, and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020, 75:2950-2973. DOI:10.1016/j.jacc.2020.04.031
Goeijenbier M, van Wissen M, van de Weg C et al. Review: Viral infections and mechanisms of thrombosis and bleeding. J Med Virol. 2012;84:1680-1696. DOI:10.1002/jmv.23354
Baccellieri D, Bertoglio L, Apruzzi L, et al.: Incidence of deep venous thrombosis in COVID-19 hospitalized patients during the first peak of the Italian outbreak. Phlebology. 2021; 36:375-383.
Loo J, Spittle DA, & Newnham M.: COVID-19 immunothrombosis and venous thromboembolism: biological mechanisms. Thorax. 2021;76:412-420. DOI:10.1136/thoraxjnl-2020-216243
Erben Y, Franco-Mesa C, Gloviczki P, et al.: Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stay in a multisite healthcare system. J of Vasc Surg. 2021;9:1361-1370.
Ameri P, Inciardi R M, Di Pasquale, et al.: Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study. Clinical research in cardiology: official journal of the German Cardiac Society. 2021;110:1020-1028.
Fauvel C, Weizman O, Trimaille A, et al.: Pulmonary embolism in COVID-19 patients: A French multicentre cohort study. EHJ. 2020; 41:3058-3068.
Poissy J, Goutay J, Caplan M, et al. F., Jeanpierre E, Rauch A, Labreuche J, Susen S, Lille ICU Haemostasis COVID-19 Group. 2020;19:184-186.
Badr OI, Alwafi H, Elrefaey WA, et al.: Incidence and Outcomes of Pulmonary Embolism among Hospitalized COVID-19 Patients. International journal of environmental research and public health. 2021;18:7645.
Miró Ò, Jiménez S, Mebazaa A, et al.: Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. EHJ. 2021;42:3127-3142. DOI:10.1093/eurheartj/ehab314
Benito N, Filella D, Mateo J, et al.: Pulmonary Thrombosis or Embolism in a Large Cohort of Hospitalized Patients With Covid-19. Frontiers. 2020;7:557. DOI:10.3389/fmed.2020.00557
Franco-Moreno A, Herrera-Morueco M, Mestre-Gómez B, et al.: Incidence of Deep Venous Thrombosis in Patients With COVID-19 and Pulmonary Embolism: Compression Ultrasound COVID Study. Journal of ultrasound in medicine: official journal of the American Institute of Ultrasound in Medicine. 2020;40:1411-1416.
Cai C, Guo Y, You Y, et al. Deep Venous Thrombosis in COVID-19 Patients: A Cohort Analysis. JIACATH. 2020; 26. DOI:10.1177/1076029620982669
Yu Y, Tu J, Lei B, et al.: Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients. JIACATH. 2020;26:1076029620953217. DOI:10.1177/1076029620953217
Xu H, Martin A, Singh A, et al.: Pulmonary Embolism in Patients Hospitalized With COVID-19 (From a New York Health System)..AJC. 2020;133:148- 153. DOI:10.1016/j.amjcard.2020.07.036
Pereira de Godoy JM, Russeff GJ, DS Costa, et al.: Mortality of Patients Infected by COVID-19 with and without Deep-Vein Thrombosis. Medicines. 2021;8:75. DOI:10.3390/medicines8120075
Fu Z, Bai G, Song B, et al.: Risk factors and mortality of pulmonary embolism in COVID-19 patients: Evidence based on fifty observational studies. Medicine, 2022;101:e29895. Medicine. DOI:10.1097/MD.0000000000029895
Ohsfeldt RL, Choong CK, Mc Collam PL, et al.: Inpatient Hospital Costs for COVID-19 Patients in the United States. Advances in therapy.2021;38:5557-5595. DOI:10.1007/s12325-021-01887-4
Giustino G, Croft LB, Oates CP, et al.: Takotsubo Cardiomyopathy in COVID-19. JAAC. 2020; 76:628-629.
Das M, Bristow MR, Chung MK: The Essential Vulnerability of Human Cardiac Myocytes to SARS-CoV-2. JACC. 2021, 6:346-349. DOI:10.1016/j.jacbts.2021.02.010
Libby P, Loscalzo J, Ridker PM, et al.: Inflammation, Immunity, and Infection in Atherothrombosis. JACC. 2018;72:2071-2081. DOI:10.1016/j.jacc.2018.08.1043
Tersalvi G, Vicenzi M, Calabretta D, et al.: Elevated Troponin in Patients With Coronavirus Disease 2019. JCF. 2019;26:470-475. DOI:10.1016/j.cardfail.2020.04.009
Majeed H, Gangu K, Sagheer S, et al.: COVID-19 and NSTEMI Outcomes among Hospitalized Patients in the United States and Racial Disparities in Mortality: Insight from National Inpatient Sample Database. Vaccines. 2022;10:2024. DOI:10.3390/vaccines10122024
Case BC, Yerasi C, Forrestal BJ, et al. Comparison of Characteristics and Outcomes of Patients With Acute Myocardial Infarction With Versus Without Coronavirus-19. AJC. 2020;144:8-12. DOI:10.1016/j.amjcard.2020.12.059
Rodriguez-Leor O, Cid Alvarez AB, Pérez de Prado A, et al.: In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients. EuroPCR. 2021;16: 1426-1433. DOI:10.4244/EIJ-D-20-00935
Choudry FA, Hamshere SM, Rathod KS, et al.: High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology. JACC. 2020;76:1168-1176.
Saad M, Kennedy KF, Imran H, et al.: Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction. JAMA. 2021;326(19):1940-1952.
Kite TA, Ludman PF, Gale CP, et al.: International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19. JACC. 2021;77:2466-2476. DOI:10.1016/j.jacc.2021.03.309
Dadras O, SeyedAlinaghi S, Karimi A, et al.: COVID-19 mortality and its predictors in the elderly: A systematic review. HSR. 2022;5(3):e657. DOI:10.1002/hsr2.657
Stefanini, G, Montorfano M, Trabattoni D, et al.: ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes. Circulation. 2020;141(25):2113-2116. DOI:10.1161/CIRCULATIONAHA.120.047525
Kaur P, Patel P, Singh B, et al.: ST-Segment Elevation in Patients with COVID-19: A Late Complication. AJMS. 2021;361:403-405. DOI:10.1016/j.amjms.2020.09.019
Muñoz-Price LS, Nattinger AB, Rivera F, et al.: racial disparities in incidence and outcomes among patients With COVID-19. JAMA .2021; 3:2021892. DOI:10.1001/jamanetworkopen.2020.21892
Dai CL, Kornilov SA, Roper RT, Cohen-Cline H, Jade K, Smith B, Heath JR, Diaz G, Goldman JD, Magis AT, Hadlock JJ. 2021;73:2193-2204.
Bangalore S, Sharma A, Slotwiner A, et al.: ST-Segment Elevation in Patients with Covid a Case Series. NEJM. 2020;382: 2478-2480. DOI:10.1056/NEJMc2009020
Hamadeh A, Aldujeli A, Briedis K, et al.: Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction. AJC. 2020;131:1-6. DOI:10.1016/j.amjcard.2020.06.063
Evbayekha E, Okorare O, Okobi O: A Year Retrospective Study on the Morbidity and Mortality Pattern of Covid-19 Patients in an Isolation Facility in Benin City. 2021;27-2021. DOI: 10.51542/ijscia.v2i4.33